Condition: Metastatic Colon Carcinoma · Stage IV Colon Cancer AJCC v8 · Stage IVA Colon Cancer AJCC v8 · Sponsor: Howard S. Hochster, MD
This phase II trial tests whether NBT-NM108 works in reducing chemotherapy-induced diarrhea in patients with colon cancer that has spread to other places in the body (metastatic). Irinotecan is one of the most used medicine for colon cancer, but it leads to diarrhea in most patients receiving it and among some of them, severe diarrhea can occur. NBT-NM108 is a high dietary fiber formula that is developed based on research findings that have shown that high fiber diets can help maintain healthy bacteria in the gut and improve gut function. Giving NBT-NM108 to patients with colon cancer receiving chemotherapy may help relieve or lessen diarrhea symptoms and lead to improved tolerance of the chemotherapy drug, irinotecan.
This description comes directly from the study's public registry record.
Howard S Hochster, MD · 732-235-2465 · howard.hochster@rutgers.edu
Always discuss trial participation with your own doctor first.
| Robert Wood Johnson University Hospital, Hamilton | Hamilton, New Jersey, United States | Recruiting |
| Monmouth Medical Center | Lakewood, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Monmouth Medical Center Southern Campus | Lakewood, New Jersey, United States | Recruiting |
| Cooperman Barnabas Medical Center | Livingston, New Jersey, United States | Recruiting |
| Robert Wood Johnson University Hospital | New Brunswick, New Jersey, United States | Recruiting |
| Rutgers Cancer Institute of New Jersey | New Brunswick, New Jersey, United States | Recruiting |
| The Cancer Center | Newark, New Jersey, United States | Recruiting |
| Newark Beth Israel Medical Center | Newark, New Jersey, United States | Recruiting |
| Robert Wood Johnson University Hospital, Somerset | Somerville, New Jersey, United States | Recruiting |
| Community Medical Center | Toms River, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05296681